uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted April 02, 2019

FDA Issues Strong Warnings to Sellers of CBD

On March 28, 2019, the FDA issued warning letters to three companies for making unsubstantiated claims about the health benefits of CBD (cannabidiol) products on their websites. The products were promoted for a range of conditions, from chronic pain and skin conditions such as psoriasis, to diabetes, Alzheimer's disease and cancer. The agency also emphasized that CBD is not permitted to be sold as a dietary supplement. Use the links below to see the full warning letter for each company:

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at